Clinical Trial Update: Long-Term Assessment of Safety and Physical Function With AMG 108 in RA [Phase 2]

View source ↗

Summary

A Phase 2 long-term study of AMG 108 in rheumatoid arthritis reports safety and physical function outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AMG 108

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED